Metabolic models predict bacterial passengers in colorectal cancer

Cancer & Metabolism

Martijn A. Huynen¹  Daniel R. Garza¹  Bas E. Dutilh¹  Rahwa Taddese²  Annemarie Boleij²  Georg Zeller³  Jakob Wirbel³ 

[1] Centre for Molecular and Biomolecular Informatics, Radboud University Medical Centre;Department of Pathology, Radboud University Medical Center;European Molecular Biology Laboratory, Structural and Computational Biology Unit;

关键词: Genome-scale metabolic models;    Colorectal cancer microbiome;    Colorectal cancer metabolome;    Bacterial driver-passenger model;   

DOI  :  10.1186/s40170-020-0208-9

来源: DOAJ

【 摘 要 】

Abstract Background Colorectal cancer (CRC) is a complex multifactorial disease. Increasing evidence suggests that the microbiome is involved in different stages of CRC initiation and progression. Beyond specific pro-oncogenic mechanisms found in pathogens, metagenomic studies indicate the existence of a microbiome signature, where particular bacterial taxa are enriched in the metagenomes of CRC patients. Here, we investigate to what extent the abundance of bacterial taxa in CRC metagenomes can be explained by the growth advantage resulting from the presence of specific CRC metabolites in the tumor microenvironment. Methods We composed lists of metabolites and bacteria that are enriched on CRC samples by reviewing metabolomics experimental literature and integrating data from metagenomic case-control studies. We computationally evaluated the growth effect of CRC enriched metabolites on over 1500 genome-based metabolic models of human microbiome bacteria. We integrated the metabolomics data and the mechanistic models by using scores that quantify the response of bacterial biomass production to CRC-enriched metabolites and used these scores to rank bacteria as potential CRC passengers. Results We found that metabolic networks of bacteria that are significantly enriched in CRC metagenomic samples either depend on metabolites that are more abundant in CRC samples or specifically benefit from these metabolites for biomass production. This suggests that metabolic alterations in the cancer environment are a major component shaping the CRC microbiome. Conclusion Here, we show with in sillico models that supplementing the intestinal environment with CRC metabolites specifically predicts the outgrowth of CRC-associated bacteria. We thus mechanistically explain why a range of CRC passenger bacteria are associated with CRC, enhancing our understanding of this disease. Our methods are applicable to other microbial communities, since it allows the systematic investigation of how shifts in the microbiome can be explained from changes in the metabolome.

【 授权许可】

Unknown